Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Mecasermin, sold under the brand name Increlex, also known as recombinant human insulin-like growth factor-1 (rhIGF-1), is a recombinant form of human insulin-like growth factor 1 (IGF-I) which is used in the long-term treatment of growth failure and short stature in children with severe primary IGF-I deficiency, for instance due to growth hormone…
Overview, Related Topics & Entities
Explore the main themes, entities and connections around Mecasermin. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
growth severe primary deficiency human insulin-like rhigf-1 half-life hours brand name also factor failure children igf-1 related complex recombinant increlex
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Mecasermin | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Mecasermin | ATC code | H01AC03 (WHO) | 1.00 | infobox |
| Mecasermin | CAS Number | 68562-41-4 N | 1.00 | infobox |
| Mecasermin | ChEMBL | ChEMBL1201716 N | 1.00 | infobox |
| Mecasermin | ChemSpider | none | 1.00 | infobox |
| Mecasermin | DrugBank | DB01277 N | 1.00 | infobox |
| Mecasermin | Elimination half-life | 5.8 hours | 1.00 | infobox |
| Mecasermin | Formula | C331H512N94O101S7 | 1.00 | infobox |
| Mecasermin | KEGG | D04870 N | 1.00 | infobox |
| Mecasermin | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Mecasermin | Legal status | CA: ℞-only / Schedule D | 1.00 | infobox |
| Mecasermin | Legal status | US: ℞-only | 1.00 | infobox |
| Mecasermin | Molar mass | 7648.71 g·mol−1 | 1.00 | infobox |
| Mecasermin | Other names | FK-780; Recombinant human insulin-like growth factor-1; rhIGF-1; Somatomedin-1 | 1.00 | infobox |
| Mecasermin | Pregnancy category | AU: B3 | 1.00 | infobox |
| Mecasermin | Routes of administration | Subcutaneous injection | 1.00 | infobox |
| Mecasermin | Trade names | Increlex | 1.00 | infobox |
| Mecasermin | UNII | 7GR9I2683O | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.